Staphylococcus aureus and Staph Methicillin-Resistant (MRSA) by Molecular Method
Methicillin-resistant Staphylococcus aureus (S. aureus) is a bacterium responsible for several difficult-to-treat infections in humans. MRSA is also known as oxacillin-resistant S. aureus (ORSA). MRSA is a strain of S. aureus that through the process of natural selection has developed resistance to beta-lactam antibiotics, which include the penicillins (methicillin, dicloxacillin, nafcillin, oxacillin, etc.), and the cephalosporins. This resistance makes MRSA infections difficult to treat with standard types of antibiotics.
The prevalence of a MRSA infection tend to occur in hospitals, prisons, and nursing homes where patients with open wounds, invasive devices, and weakened immune systems are at greater risk of infection than the general public. S. aureus is a significant cause of community-acquired and nosocomial infections. Antimicrobial resistance to methicillin is on the rise, complicating patient management. S. aureus bacteremia increase one’s risk of death, and most studies have shown an increase in mortality among patients infected with methicillin-resistant S. aureus (MRSA) compared to those infected with methicillin-susceptible S. aureus (MSSA).
Traditionally, the detection of bloodstream infections caused by S. aureus required at least a day for culture and another day for identification and susceptibility testing. Nucleic acid amplification methods (polymerase change reaction method) can provide same-day results once the blood cultures are positive for microbial growth. A rapid PCR type diagnostic test to detect bacteremia caused by S. aureus and MRSA has great potential to reduce mortality, the length of hospitalization, and the costs associated with bloodstream infections.
- To detect the presence of MRSA or colonization of MRSA in nasal specimens
- To establish a decolonization regime to potentially reduce the likelihood of a subsequent MRSA infection
- Rule out MRSA infections in suspected individuals
- Not used to diagnosis MRSA infection
- Not used to guide or monitor treatment for an MRSA infection
Positive Result:
- In infected patients with MRSA
- Carriers carrying asymptomatically MRSA
Physician should be informed immediately if MRSA detected.
Not Detected (Negative)
Collect nasal swab using a sterile swab collected in BD Liquid Stuart medium. (use commercially available product supplied by BD) or eSwab with Liquid Amies, other swabs.
Stability
- Ambient: 1-3 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- J Hosp Infect. 65:24-28. [PMID: 17145100]
- J Clin Microbiol. 44:1604-1605. [PMID: 16597911]
- Proc Natl Acad Sci USA 103: 5620-5625. [PMID: 16565219]
- Am J Med. 2006 Jun;119(6 Suppl 1):S45-52. [PMID: 16735151]
- J Hosp Infect. 2006 May;63 Suppl 1:S1-44. [PMID: 16581155]